Arrowhead Pharmaceuticals (NASDAQ:ARWR) shared initial interim clinical results from two RNA interference (RNAi) obesity ...
The ClearBridge Energy Midstream Opportunity Fund (EMO) offers a 9.74% yield by investing in large-cap midstream energy ...
New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, ...
InflaRx to prioritize izicopan as its leading pipeline asset, with a goal of continuing toward Phase 2b readiness in ...
Tech Xplore on MSN
AI data centers could stabilize the power grid
The rapid development and widespread use of artificial intelligence (AI) systems is posing new challenges for electricity ...
CK0804, a novel Treg therapy, gains FDA orphan drug status for myelofibrosis, promising new hope for patients with limited treatment options. CK0804, an investigational allogeneic regulatory T cell ...
The Newsom administration released the proposal Friday for the upcoming 2026-27 budget year, which acts as a starting point ...
A blood-based colorectal cancer (CRC) screening test, SimpleScreen™, has shown a significant leap in performance, ...
ASN Kidney Week, held in November, featured leading-edge science in kidney care, with evidence supporting new drugs to treat ...
An analysis from energy policy group AnnDyl shows significant potential benefits for local grids, employment and utility ...
KELOWNA, BC / / December 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the "Company" or "Lexaria"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback